证券之星消息，2月27日南向资金减持13.41万股微创医疗（00853.HK）。近5个交易日中，获南向资金 增持的有3天，累计净增持168.96万股。近20个交易日中，获南向资金增持的有14天，累计净增持 1470.22万股。截至目前，南向资金持有微创医疗（00853.HK）9.26亿股，占公司已发行普通股的 48.28%。 微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公 司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器 械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大 动脉及外周血管介入业务分部包括"L-REBOA"主动脉阻断球囊等产品。神经介入业务分部包括脑动脉 粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人 业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公 司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器 械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大 动脉及外周血管介入业务分部包括"L-REBOA"主动脉阻断球囊等产品。神经介入业务分部包括脑动脉 粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人 业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月26日南向资金增持161.11万股微创医疗（00853.HK）。近5个交易日中，获南向资金 增持的有4天，累计净增持242.47万股。近20个交易日中，获南向资金增持的有15天，累计净增持1842.8 万股。截至目前，南向资金持有微创医疗（00853.HK）9.26亿股，占公司已发行普通股的48.28%。 ...

Core Insights - Southbound funds increased their holdings in MicroPort Medical (00853.HK) by 1.4415 million shares on February 13, with net increases recorded on 4 out of the last 5 trading days, totaling 676,500 shares [1] - Over the past 20 trading days, there have been net increases on 15 days, amounting to 20.3817 million shares [1] - Currently, southbound funds hold 926 million shares of MicroPort Medical, representing 48.26% of the company's total issued ordinary shares [1] Company Overview - MicroPort Medical Science Co., Ltd. is primarily engaged in the sales, production, research, and development (R&D) of medical devices [1] - The company operates through eight divisions, including: - Cardiovascular Interventional Business: Products include implantable devices and access devices [1] - Orthopedic Medical Devices: Focuses on joint reconstruction and spinal devices [1] - Cardiac Rhythm Management (CRM): Includes pacemakers and defibrillators [1] - Aortic and Peripheral Vascular Interventional Business: Features products like the "L-REBOA" aortic occlusion balloon [1] - Neurointerventional Business: Involves products for carotid artery atherosclerosis and coils [1] - Structural Heart Disease Business: Engages in transcatheter aortic valve implantation [1] - Surgical Robotics Business: Manufactures and develops surgical robotic devices [1] - Surgical Medical Devices Business: Focuses on the manufacturing and R&D of surgical medical devices [1]

Core Viewpoint - Southbound funds have reduced their holdings in MicroPort Scientific Corporation (00853.HK) by 1.72 million shares on February 11, with a total net reduction of 2.70 million shares over the past five trading days [1] Group 1: Shareholding Changes - In the last 20 trading days, southbound funds have increased their holdings on 14 days, resulting in a total net increase of 22.13 million shares [1] - Currently, southbound funds hold 924 million shares of MicroPort, accounting for 48.16% of the company's total issued ordinary shares [1] Group 2: Company Overview - MicroPort Scientific Corporation is primarily engaged in the sales, production, research, and development of medical devices [1] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [1]

Group 1 - The core point of the article is that southbound funds have increased their holdings in MicroPort Medical (00853.HK) by 60,000 shares on February 9, 2026, while experiencing a net reduction of 2.5329 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings in MicroPort Medical on 13 occasions, with a total net increase of 16.2003 million shares [1] - As of now, southbound funds hold 925 million shares of MicroPort Medical, accounting for 48.23% of the company's total issued ordinary shares [1] Group 2 - The total number of shares held by southbound funds on February 9, 2026, is 925 million, with a change of 60,000 shares, reflecting a change of 0.01% [2] - On February 6, 2026, there was a reduction of 1.5155 million shares, representing a decrease of 0.16% [2] - The company operates in the medical device sector, focusing on sales, production, research, and development through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, and surgical robotics [2]

Core Viewpoint - Southbound funds reduced their holdings in MicroPort Scientific Corporation (00853.HK) by 3.83 million shares on February 4, indicating a fluctuation in investor sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, southbound funds increased their holdings on three occasions, with a total net increase of 117,100 shares [1] - In the last twenty trading days, there were fourteen days of net increases, totaling 25.75 million shares [1] - Currently, southbound funds hold 926 million shares of MicroPort, representing a significant portion of the company's issued ordinary shares [1] Group 2: Company Overview - MicroPort Scientific Corporation is primarily engaged in the sales, production, research, and development of medical devices [1] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [1]

Core Viewpoint - Southbound funds have significantly increased their holdings in MicroPort Medical (00853.HK), indicating strong investor interest and confidence in the company's future prospects [1] Group 1: Southbound Fund Activity - On January 23, southbound funds increased their holdings by 1.6216 million shares of MicroPort Medical [1] - Over the past five trading days, there have been four days of net increases, totaling 7.5492 million shares [1] - In the last 20 trading days, there were 16 days of net increases, amounting to 33.0996 million shares [1] - Currently, southbound funds hold 913 million shares of MicroPort Medical, representing a significant portion of the company's issued ordinary shares [1] Group 2: Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices [1] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [1]

Group 1 - The core point of the article highlights that southbound funds have increased their holdings in MicroPort Medical (00853.HK) by 3.5917 million shares on January 22, 2026, marking a positive trend in investment interest [1] - Over the past five trading days, southbound funds have increased their holdings on four occasions, with a total net increase of 10.374 million shares [1] - In the last twenty trading days, there have been fifteen days of net increases in holdings, totaling 31.3323 million shares [1] Group 2 - As of January 22, 2026, southbound funds hold a total of 911 million shares of MicroPort Medical, which represents a significant portion of the company's issued ordinary shares [1] - The daily changes in shareholding for the last five trading days show fluctuations, with the largest increase being 4.4877 million shares on January 19, 2026, and a decrease of 2.0648 million shares on January 20, 2026 [2] - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices, operating through eight business segments including cardiovascular intervention, orthopedic medical devices, and surgical robotics [2]

Core Viewpoint - Southbound funds have increased their holdings in MicroPort Medical (00853.HK) by 3.4078 million shares on January 8, 2026, indicating a positive trend in investor sentiment towards the company [1]. Group 1: Shareholding Changes - Over the past five trading days, Southbound funds have increased their holdings for five days, with a total net increase of 20.3882 million shares [1]. - In the last twenty trading days, there were seven days of net reduction in holdings, totaling 442,100 shares [1]. - As of now, Southbound funds hold 904 million shares of MicroPort Medical, accounting for 47.24% of the company's total issued ordinary shares [1]. Group 2: Shareholding Data - On January 8, 2026, the total number of shares held was 904 million, with a change of 3.4078 million shares, reflecting a 0.38% increase [2]. - On January 7, 2026, the total number of shares held was 901 million, with a change of 2.0976 million shares, reflecting a 0.23% increase [2]. - On January 5, 2026, the total number of shares held was 898 million, with a change of 3.3146 million shares, reflecting a 0.37% increase [2]. - On January 2, 2026, the total number of shares held was 2,556.8 million, with a change of 9.0958 million shares, reflecting a 1.03% increase [2]. - On December 30, 2025, the total number of shares held was 886 million, with a change of 2.4725 million shares, reflecting a 0.28% increase [2]. Group 3: Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices, operating through eight divisions [2]. - The cardiovascular intervention division includes products such as implantable devices and access devices [2]. - The orthopedic medical device division includes instruments for joint reconstruction and spinal applications [2]. - The cardiac rhythm management (CRM) division includes devices such as pacemakers and defibrillators [2]. - The aortic and peripheral vascular intervention division includes products like the "L-REBOA" aortic occlusion balloon [2]. - The neuro-intervention division includes products for treating cerebral artery atherosclerosis and coils [2]. - The structural heart disease division includes products for transcatheter aortic valve implantation [2]. - The surgical robotics division is involved in the manufacturing and R&D of surgical robotic instruments [2]. - The surgical medical device division focuses on the manufacturing and R&D of surgical medical devices [2].

Group 1 - The core point of the article is that southbound funds have increased their holdings in MicroPort Medical (00853.HK) by 3.31 million shares on January 5, 2026, with a total net increase of 16.43 million shares over the past five trading days [1] - Over the last 20 trading days, there were 7 days of net reductions in holdings, totaling 1.05 million shares [1] - As of now, southbound funds hold 899 million shares of MicroPort Medical, accounting for 46.96% of the company's total issued ordinary shares [1] Group 2 - The total number of shares held by southbound funds on January 5, 2026, was 899 million, reflecting a change of 3.31 million shares, which is a 0.37% increase [2] - The previous trading days showed significant changes, with an increase of 9.10 million shares (1.03%) on January 2, 2026, and smaller increases on December 30, 2025 (0.28%), December 29, 2025 (0.16%), and December 23, 2025 (0.02%) [2] - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices, operating through eight divisions including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, and surgical robotics [2]